Zhejiang Medicine Co Ltd (600216) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Zhejiang Medicine Co Ltd (600216) has a cash flow conversion efficiency ratio of 0.062x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥690.77 Million ≈ $101.08 Million USD) by net assets (CN¥11.21 Billion ≈ $1.64 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see 600216 market cap for the company's overall valuation and market capitalisation.
Zhejiang Medicine Co Ltd - Cash Flow Conversion Efficiency Trend (1998–2025)
This chart illustrates how Zhejiang Medicine Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Zhejiang Medicine Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Zhejiang Medicine Co Ltd ranked by their cash flow conversion efficiency. Explore Zhejiang Medicine Co Ltd (600216) cash earnings ratio to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Dime Community Bancshares, Inc.
NYSE:DCOM
|
0.037x |
|
OVH Groupe SAS
PA:OVH
|
10.219x |
|
Zydus Wellness Limited
NSE:ZYDUSWELL
|
0.070x |
|
Tianjin Port Co Ltd
SHG:600717
|
0.036x |
|
Zymeworks Inc. Common Stock
NASDAQ:ZYME
|
-0.098x |
|
Woolworths Holdings Ltd
JSE:WHL
|
0.247x |
|
Guangdong Rongtai Industry Co Ltd
SHG:600589
|
-0.022x |
|
National Bank Holdings Corporation
NYSE:NBHC
|
0.081x |
Annual Cash Flow Conversion Efficiency for Zhejiang Medicine Co Ltd (1998–2025)
The table below shows the annual cash flow conversion efficiency of Zhejiang Medicine Co Ltd from 1998 to 2025. View Zhejiang Medicine Co Ltd (600216) stock price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥11.09 Billion ≈ $1.62 Billion |
CN¥1.89 Billion ≈ $275.95 Million |
0.170x | +51.08% |
| 2024-12-31 | CN¥10.87 Billion ≈ $1.59 Billion |
CN¥1.22 Billion ≈ $179.01 Million |
0.113x | +77.21% |
| 2023-12-31 | CN¥9.99 Billion ≈ $1.46 Billion |
CN¥634.31 Million ≈ $92.82 Million |
0.064x | +18.47% |
| 2022-12-31 | CN¥9.71 Billion ≈ $1.42 Billion |
CN¥520.60 Million ≈ $76.18 Million |
0.054x | -56.69% |
| 2021-12-31 | CN¥9.18 Billion ≈ $1.34 Billion |
CN¥1.14 Billion ≈ $166.33 Million |
0.124x | -20.90% |
| 2020-12-31 | CN¥8.03 Billion ≈ $1.18 Billion |
CN¥1.26 Billion ≈ $183.90 Million |
0.157x | +188.76% |
| 2019-12-31 | CN¥8.25 Billion ≈ $1.21 Billion |
CN¥447.25 Million ≈ $65.45 Million |
0.054x | -24.45% |
| 2018-12-31 | CN¥8.08 Billion ≈ $1.18 Billion |
CN¥579.91 Million ≈ $84.86 Million |
0.072x | +10.84% |
| 2017-12-31 | CN¥7.78 Billion ≈ $1.14 Billion |
CN¥503.47 Million ≈ $73.67 Million |
0.065x | +34.62% |
| 2016-12-31 | CN¥6.99 Billion ≈ $1.02 Billion |
CN¥336.14 Million ≈ $49.19 Million |
0.048x | +198.51% |
| 2015-12-31 | CN¥6.62 Billion ≈ $968.00 Million |
CN¥106.54 Million ≈ $15.59 Million |
0.016x | -80.78% |
| 2014-12-31 | CN¥6.56 Billion ≈ $960.18 Million |
CN¥549.90 Million ≈ $80.47 Million |
0.084x | -17.10% |
| 2013-12-31 | CN¥6.48 Billion ≈ $948.29 Million |
CN¥655.09 Million ≈ $95.86 Million |
0.101x | -22.42% |
| 2012-12-31 | CN¥6.20 Billion ≈ $906.81 Million |
CN¥807.49 Million ≈ $118.16 Million |
0.130x | -37.18% |
| 2011-12-31 | CN¥4.40 Billion ≈ $643.92 Million |
CN¥912.75 Million ≈ $133.56 Million |
0.207x | -39.12% |
| 2010-12-31 | CN¥3.86 Billion ≈ $565.33 Million |
CN¥1.32 Billion ≈ $192.62 Million |
0.341x | -33.46% |
| 2009-12-31 | CN¥2.86 Billion ≈ $418.70 Million |
CN¥1.47 Billion ≈ $214.39 Million |
0.512x | -22.67% |
| 2008-12-31 | CN¥1.81 Billion ≈ $265.19 Million |
CN¥1.20 Billion ≈ $175.59 Million |
0.662x | +154.11% |
| 2007-12-31 | CN¥873.73 Million ≈ $127.85 Million |
CN¥227.67 Million ≈ $33.32 Million |
0.261x | +19.49% |
| 2006-12-31 | CN¥777.31 Million ≈ $113.74 Million |
CN¥169.51 Million ≈ $24.80 Million |
0.218x | +535.06% |
| 2005-12-31 | CN¥732.23 Million ≈ $107.15 Million |
CN¥25.14 Million ≈ $3.68 Million |
0.034x | -79.39% |
| 2004-12-31 | CN¥645.68 Million ≈ $94.48 Million |
CN¥107.60 Million ≈ $15.75 Million |
0.167x | +58.20% |
| 2003-12-31 | CN¥628.48 Million ≈ $91.97 Million |
CN¥66.20 Million ≈ $9.69 Million |
0.105x | +186.82% |
| 2002-12-31 | CN¥629.71 Million ≈ $92.15 Million |
CN¥23.13 Million ≈ $3.38 Million |
0.037x | -77.25% |
| 2001-12-31 | CN¥608.50 Million ≈ $89.04 Million |
CN¥98.25 Million ≈ $14.38 Million |
0.161x | +868.83% |
| 2000-12-31 | CN¥635.03 Million ≈ $92.92 Million |
CN¥10.58 Million ≈ $1.55 Million |
0.017x | +120.07% |
| 1999-12-31 | CN¥625.07 Million ≈ $91.47 Million |
CN¥-51.90 Million ≈ $-7.60 Million |
-0.083x | -150.15% |
| 1998-12-31 | CN¥348.61 Million ≈ $51.01 Million |
CN¥57.72 Million ≈ $8.45 Million |
0.166x | -- |
About Zhejiang Medicine Co Ltd
Zhejiang Medicine Co., Ltd. manufactures and sells life nutrition and pharmaceuticals products in China and internationally. The company offers synthetic vitamin E, vitamin A, natural vitamin E, ß-carotene, canthaxanthin, vancomycin hydrochloride, teicoplanin, and daptomycin. It also provides fat-soluble vitamins, quinolone antibiotics, anti-drug-resistant antibiotics, and other products, as well… Read more